Skip to content

Supportive Health

LH and FSH

Luteinizing hormone and follicle-stimulating hormone: two pituitary hormones that signal the testes and ovaries to make sex hormones and sperm or eggs.

By the glp1.how editorial teamReviewed

LH (luteinizing hormone) and FSH (follicle-stimulating hormone) are gonadotropins: hormones released by the pituitary gland, under direction from the hypothalamus, that control the testes and ovaries. In men, LH tells the testes to make testosterone and FSH supports sperm production. In women, FSH grows the ovarian follicles that hold eggs, and a mid-cycle surge of LH triggers ovulation. Doctors measure them in blood tests to work out where a hormone problem starts: low testosterone with low or normal LH points to the brain-pituitary signal, while high LH points to the testes themselves.

They matter on a GLP-1 for a few reasons. Obesity can suppress the LH signal in men, which is one reason testosterone often rises with weight loss. Taking testosterone therapy does the opposite, shutting down LH and FSH, which is why it can reduce sperm production. In women, a high LH-to-FSH ratio is common in PCOS, and ovulation can return as weight comes off. See men's health on a GLP-1 and women's health on a GLP-1.

Source: MedlinePlus (external link).

lhfshhormonesfertilitytestosteroneglossary

Revision history

Updated 2 times since Sep 26, 2026 · show changes
  1. v3

    Body revised

  2. v2

    Published

  3. v1

    First version

Related guides

  • Men's health on a GLP-1: testosterone, fertility, muscle, and the things worth watching · For men, losing weight on a GLP-1 can raise testosterone that obesity was holding down, and unlike testosterone therapy it seems to leave fertility intact. This guide covers what the research shows so far on testosterone, sexual function and sperm, muscle and bone, heart health and sleep apnea, and why the routine checkup matters more on these medications.
  • How GLP-1 medications affect men vs. women: what the sex differences actually are · The same GLP-1 medication doesn't act quite the same in men and women. On average women lose more weight, report more side effects, and absorb more of the drug at the same body weight, differences driven partly by estrogen and testosterone. This guide covers what the research shows about sex differences in weight loss, tolerability, blood sugar and biology, and what it means for what you should expect.
  • Women's health on a GLP-1: birth control, pregnancy, PCOS, bone, and the things worth watching · For women, the biggest GLP-1 question is fertility. Tirzepatide can make the pill less reliable, weight loss can bring back ovulation you weren't expecting, and none of these drugs is safe in pregnancy, which is why "Ozempic babies" happen. This guide covers contraception and pregnancy planning, the PCOS trial evidence, protecting bone and muscle, the heart, and the menopause overlap.
  • HRT for men (testosterone) and GLP-1 medications: what the connection really is · Low testosterone and excess weight are linked, but the cause often runs from the weight to the testosterone, and that changes when testosterone therapy actually helps. This guide covers who benefits from TRT and why losing weight on a GLP-1 can raise testosterone on its own.
  • CPAP as the weight comes off: managing sleep apnea on a GLP-1 · Tirzepatide (Zepbound) roughly halved sleep apnea severity in the SURMOUNT-OSA trials, and 42 to 50% of participants reached the trial's definition of resolution. That still left many with apnea, and the trials never tested stopping CPAP for good. This guide covers why you shouldn't retire your machine on your own, how pressure and mask fit change as weight comes off, when and how a repeat sleep test happens, and how an OSA diagnosis affects Zepbound coverage (as of September 2026).
  • Protecting your bones on a GLP-1: bone density, fracture risk, and what actually helps · Losing a lot of weight usually costs a small amount of bone, mostly at the hip, and GLP-1 weight loss is no exception. So far the fracture data are reassuring and the drug itself does not look like the main cause, but the long-term evidence is thin. Here's what the bone-density and fracture studies show, who should pay the most attention, and the levers that kept bone steady in trials: resistance and impact training, protein, calcium and vitamin D, and a well-timed bone scan.

Related terms

  • GLP-1 · A gut hormone (glucagon-like peptide-1) that stimulates insulin release, slows digestion, and reduces appetite; the target of drugs like semaglutide and liraglutide.
  • Polycystic ovary syndrome (PCOS) · A common hormonal condition in women involving irregular or absent periods, higher androgen levels, and frequently insulin resistance and weight gain; GLP-1 medications are increasingly used for weight management in PCOS.

Was this helpful?

Improve this page